| Chronic pancreatitis G Beyer, A Habtezion, J Werner, MM Lerch, J Mayerle The Lancet 396 (10249), 499-512, 2020 | 344 | 2020 |
| Genetics, cell biology, and pathophysiology of pancreatitis J Mayerle, M Sendler, E Hegyi, G Beyer, MM Lerch, M Sahin-Tóth Gastroenterology 156 (7), 1951-1968. e1, 2019 | 268 | 2019 |
| Acute pancreatitis: diagnosis and treatment P Szatmary, T Grammatikopoulos, W Cai, W Huang, R Mukherjee, ... Drugs 82 (12), 1251-1276, 2022 | 184 | 2022 |
| Immune cell and stromal signature associated with progression-free survival of patients with resected pancreatic ductal adenocarcinoma UM Mahajan, E Langhoff, E Goni, E Costello, W Greenhalf, C Halloran, ... Gastroenterology 155 (5), 1625-1639. e2, 2018 | 165 | 2018 |
| Prognostic and predictive markers in pancreatic adenocarcinoma N Le, M Sund, A Vinci, G Beyer, MA Javed, S Krug, A Neessee, ... Digestive and Liver Disease 48 (3), 223-230, 2016 | 143 | 2016 |
| Complement component 5 mediates development of fibrosis, via activation of stellate cells, in 2 mouse models of chronic pancreatitis M Sendler, G Beyer, UM Mahajan, V Kauschke, S Maertin, C Schurmann, ... Gastroenterology 149 (3), 765-776. e10, 2015 | 98 | 2015 |
| Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F AR Oliveira, G Beyer, R Chugh, SJ Skube, K Majumder, S Banerjee, ... Laboratory investigation 95 (6), 648-659, 2015 | 66 | 2015 |
| Development and validation of a chronic pancreatitis prognosis score in 2 independent cohorts G Beyer, UM Mahajan, C Budde, TJ Bulla, T Kohlmann, L Kuhlmann, ... Gastroenterology 153 (6), 1544-1554. e2, 2017 | 52 | 2017 |
| S3-leitlinie pankreatitis–leitlinie der deutschen gesellschaft für gastroenterologie, verdauungs-und stoffwechselkrankheiten (DGVS)–september 2021–AWMF registernummer 021-003 G Beyer, A Hoffmeister, P Michl, TM Gress, W Huber, H Algül, A Neesse, ... Zeitschrift für Gastroenterologie 60 (03), 419-521, 2022 | 48 | 2022 |
| Prospective cohort study comparing transient EUS guided elastography to EUS-FNA for the diagnosis of solid pancreatic mass lesions J Mayerle, G Beyer, P Simon, EJ Dickson, RC Carter, F Duthie, MM Lerch, ... Pancreatology 16 (1), 110-114, 2016 | 44 | 2016 |
| IgG4-related disease: a new kid on the block or an old aquaintance? G Beyer, T Schwaiger, MM Lerch, J Mayerle United European Gastroenterology Journal 2 (3), 165-172, 2014 | 44 | 2014 |
| Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe MA Javed, G Beyer, N Le, A Vinci, H Wong, D Palmer, RD Morgan, ... Pancreatology 19 (1), 97-104, 2019 | 38 | 2019 |
| Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non … MG Adam, G Beyer, N Christiansen, B Kamlage, C Pilarsky, M Distler, ... Gut 70 (11), 2150-2158, 2021 | 34 | 2021 |
| Tumor-specific delivery of 5-fluorouracil–incorporated epidermal growth factor receptor–targeted aptamers as an efficient treatment in pancreatic ductal adenocarcinoma models UM Mahajan, Q Li, A Alnatsha, J Maas, M Orth, SH Maier, J Peterhansl, ... Gastroenterology 161 (3), 996-1010. e1, 2021 | 28 | 2021 |
| Risk stratification and early conservative treatment of acute pancreatitis M Żorniak, G Beyer, J Mayerle Visceral medicine 35 (2), 82-89, 2019 | 26 | 2019 |
| New advances in the treatment of metastatic pancreatic cancer M Schober, MA Javed, G Beyer, N Le, A Vinci, M Sund, A Neesse, S Krug Digestion 92 (3), 175-184, 2015 | 26 | 2015 |
| Acute and Chronic Pancreatitis G Beyer, A Hoffmeister, P Lorenz, P Lynen, MM Lerch, J Mayerle Deutsches Ärzteblatt International 119 (29-30), 495, 2022 | 24 | 2022 |
| Recommendations for a more organized and effective approach to the early detection of pancreatic cancer from the PRECEDE (pancreatic cancer early detection) consortium TA Gonda, JN Everett, M Wallace, DM Simeone, L Amundadottir, G Beyer, ... Gastroenterology 161 (6), 1751-1757, 2021 | 24 | 2021 |
| Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis UM Mahajan, B Oehrle, S Sirtl, A Alnatsha, E Goni, I Regel, G Beyer, ... Gastroenterology 163 (5), 1407-1422, 2022 | 21 | 2022 |
| Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study FEM de Rijk, CL van Veldhuisen, MG Besselink, JE van Hooft, ... Pancreatology 22 (4), 457-465, 2022 | 21 | 2022 |
Markus M. LerchProfessor of Medicine, Physician-in-Chief, CEO, LMU University Hospital, MunichVerified email at med.uni-muenchen.de
